360 High-Risk Vulnerability Immunization Tool V2.0 vs VISSBOX: Side-by-Side Comparison (2026)

360 High-Risk Vulnerability Immunization Tool V2.0: Tool that immunizes Windows systems against critical vulnerabilities. built by 360 Security Group (Qihoo 360). Core capabilities include Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation..

VISSBOX: The Condom for your PC - shielding Endpoints from remote code execution and attacks. built by VISS. Core capabilities include Unidirectional optical data flow enforcing one-way network communication, Hardware-level physical separation between network and endpoint, Immutable OS with automatic reset to clean state on power cycle..

Both serve the Endpoint Protection Platform market but differ in approach, feature depth, and target audience.

360 High-Risk Vulnerability Immunization Tool V2.0 differentiates with Remote desktop vulnerability immunization (CVE-2019-0708, CVE-2019-1181, CVE-2019-1182), MS17-010 SMB vulnerability protection against ransomware, Meltdown CPU vulnerability mitigation. VISSBOX differentiates with Unidirectional optical data flow enforcing one-way network communication, Hardware-level physical separation between network and endpoint, Immutable OS with automatic reset to clean state on power cycle.

360 High-Risk Vulnerability Immunization Tool V2.0 is developed by 360 Security Group (Qihoo 360). VISSBOX is developed by VISS. Vendor maturity, funding stage, and team size can be important factors when evaluating long-term viability and support quality.

360 High-Risk Vulnerability Immunization Tool V2.0 and VISSBOX serve similar Endpoint Protection Platform use cases: both are Endpoint Protection Platform tools, both cover Zero Day. Review the feature comparison above to determine which fits your requirements.